Asset Details
MbrlCatalogueTitleDetail
Do you wish to reserve the book?
Not So Rare: Diseases Based on Mutant Proteins Controlling Endoplasmic Reticulum-Mitochondria Contact (MERC) Tethering
by
Makio, Tadashi
, Simmen, Thomas
in
Ataxia
/ Calcium (mitochondrial)
/ Calcium ions
/ Calcium metabolism
/ Deafness
/ Defects
/ Endoplasmic reticulum
/ Epilepsy
/ Genetic disorders
/ Intellectual disabilities
/ Krebs cycle
/ Lipid metabolism
/ Lipid rafts
/ Lipids
/ Mitochondria
/ Organelles
/ Oxidative metabolism
/ Oxidative phosphorylation
/ Peripheral neuropathy
/ Phosphorylation
/ Proteins
/ Rare diseases
/ Reactive oxygen species
/ Regulatory proteins
/ Seizures
/ Skeletal muscle
/ Tethering
/ Tethers
/ Tricarboxylic acid cycle
2024
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Not So Rare: Diseases Based on Mutant Proteins Controlling Endoplasmic Reticulum-Mitochondria Contact (MERC) Tethering
by
Makio, Tadashi
, Simmen, Thomas
in
Ataxia
/ Calcium (mitochondrial)
/ Calcium ions
/ Calcium metabolism
/ Deafness
/ Defects
/ Endoplasmic reticulum
/ Epilepsy
/ Genetic disorders
/ Intellectual disabilities
/ Krebs cycle
/ Lipid metabolism
/ Lipid rafts
/ Lipids
/ Mitochondria
/ Organelles
/ Oxidative metabolism
/ Oxidative phosphorylation
/ Peripheral neuropathy
/ Phosphorylation
/ Proteins
/ Rare diseases
/ Reactive oxygen species
/ Regulatory proteins
/ Seizures
/ Skeletal muscle
/ Tethering
/ Tethers
/ Tricarboxylic acid cycle
2024
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
Not So Rare: Diseases Based on Mutant Proteins Controlling Endoplasmic Reticulum-Mitochondria Contact (MERC) Tethering
by
Makio, Tadashi
, Simmen, Thomas
in
Ataxia
/ Calcium (mitochondrial)
/ Calcium ions
/ Calcium metabolism
/ Deafness
/ Defects
/ Endoplasmic reticulum
/ Epilepsy
/ Genetic disorders
/ Intellectual disabilities
/ Krebs cycle
/ Lipid metabolism
/ Lipid rafts
/ Lipids
/ Mitochondria
/ Organelles
/ Oxidative metabolism
/ Oxidative phosphorylation
/ Peripheral neuropathy
/ Phosphorylation
/ Proteins
/ Rare diseases
/ Reactive oxygen species
/ Regulatory proteins
/ Seizures
/ Skeletal muscle
/ Tethering
/ Tethers
/ Tricarboxylic acid cycle
2024
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Not So Rare: Diseases Based on Mutant Proteins Controlling Endoplasmic Reticulum-Mitochondria Contact (MERC) Tethering
Journal Article
Not So Rare: Diseases Based on Mutant Proteins Controlling Endoplasmic Reticulum-Mitochondria Contact (MERC) Tethering
2024
Request Book From Autostore
and Choose the Collection Method
Overview
Mitochondria-endoplasmic reticulum contacts (MERCs), also called endoplasmic reticulum (ER)-mitochondria contact sites (ERMCS), are the membrane domains, where these two organelles exchange lipids, Ca2+ ions, and reactive oxygen species. This crosstalk is a major determinant of cell metabolism, since it allows the ER to control mitochondrial oxidative phosphorylation and the Krebs cycle, while conversely, it allows the mitochondria to provide sufficient ATP to control ER proteostasis. MERC metabolic signaling is under the control of tethers and a multitude of regulatory proteins. Many of these proteins have recently been discovered to give rise to rare diseases if their genes are mutated. Surprisingly, these diseases share important hallmarks and cause neurological defects, sometimes paired with, or replaced by skeletal muscle deficiency. Typical symptoms include developmental delay, intellectual disability, facial dysmorphism and ophthalmologic defects. Seizures, epilepsy, deafness, ataxia, or peripheral neuropathy can also occur upon mutation of a MERC protein. Given that most MERC tethers and regulatory proteins have secondary functions, some MERC protein-based diseases do not fit into this categorization. Typically, however, the proteins affected in those diseases have dominant functions unrelated to their roles in MERCs tethering or their regulation. We are discussing avenues to pharmacologically target genetic diseases leading to MERC defects, based on our novel insight that MERC defects lead to common characteristics in rare diseases. These shared characteristics of MERCs disorders raise the hope that they may allow for similar treatment options.
This website uses cookies to ensure you get the best experience on our website.